Showing results (421-430 of 640) with videos related to

Sort By:
Pageof 64
Journal of the American Geriatrics Society|April 3, 2018
One-Year Effect of the Medicare Annual Wellness Visit on Detection of Cognitive Impairment: A Cohort StudyNicole R Fowler, Noll L Campbell, Gerhardt M Pohl, et al.
Oncoimmunology|December 15, 2018
IL-33 delays metastatic peritoneal cancer progression inducing an allergic microenvironmentAlfredo Perales-Puchalt, Nikolaos Svoronos, Daniel O Villarreal, et al.
NAR Cancer|March 21, 2025
TRIP13 protects pancreatic cancer cells against intrinsic and therapy-induced DNA replication stressJay R Anand, Gaith N Droby, Sayali Joseph, et al.
European Journal of Nuclear Medicine and Molecular Imaging|January 15, 2004
Initial experience with a prototype dual-crystal (LSO/NaI) dual-head coincidence camera in oncologyUrvi Joshi, Otto S Hoekstra, Ronald Boellaard, et al.
The Journal of Thoracic and Cardiovascular Surgery|February 21, 2023
Factors associated with morbidity, mortality, and hemodynamic failure after biventricular conversion in borderline hypoplastic left heartsMeaghan J Beattie, Lynn A Sleeper, Minmin Lu, et al.
British Journal of Haematology|August 16, 2021
Comparison of venous thromboembolism incidence in newly diagnosed multiple myeloma patients receiving bortezomib, lenalidomide, dexamethasone (RVD) or carfilzomib, lenalidomide, dexamethasone (KRD) with aspirin or rivaroxaban thromboprophylaxisKatrina Piedra, Tim Peterson, Carlyn Tan, et al.
British Journal of Haematology|February 7, 2020
Comparison of MALDI-TOF mass spectrometry analysis of peripheral blood and bone marrow-based flow cytometry for tracking measurable residual disease in patients with multiple myelomaMarion Eveillard, Even Rustad, Mikhail Roshal, et al.
Journal of Clinical Immunology|February 20, 2007
Immunomodulatory drug CC-4047 is a cell-type and stimulus-selective transcriptional inhibitor of cyclooxygenase 2Gregory D Ferguson, Kristen Jensen-Pergakes, Candice Wilkey, et al.
ACR Open Rheumatology|June 26, 2025
Safety, Tolerability, Efficacy, Pharmacokinetics, and Pharmacodynamics of Afimetoran, a Toll-Like Receptor 7 and 8 Inhibitor, in Patients With Cutaneous Lupus Erythematosus: A Phase 1b Randomized, Double-Blind, Placebo-Controlled StudyFareeda Hosein, Stanislav Ignatenko, Kristina D Chadwick, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|September 21, 2023
Brief Report: HIV Drug Resistance Assessment Among Women Who Seroconverted During the MTN-025/HOPE Open-Label Extension Dapivirine Vaginal Ring TrialUrvi M Parikh, Kerri J Penrose, Amy L Heaps, et al.
Pageof 64